[1]
“Levels of neuroinflammation markers in type 2 diabetes mellitus patients with diabetic retinopathy and genetically determined hyperhomocysteinemia”, Ukr. j. ophthalmol. , no. 4, pp. 28–37, Aug. 2024, doi: 10.31288/oftalmolzh202442837.